(Q47287831)

English

Comparison of the effects of pioglitazone and voglibose on circulating total and high-molecular-weight adiponectin, and on two fibrinolysis inhibitors, in patients with Type 2 diabetes

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/17509067

Comparison of the effects of pioglitazone and voglibose on circulating total and high-molecular-weight adiponectin, and on two fibrinolysis inhibitors, in patients with Type 2 diabetes (English)

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/17509067

type 2 diabetes

0 references

1 reference

based on heuristic

inferred from title

author name string

Y Aso

1

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/17509067

R Yamamoto

2

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/17509067

M Suetsugu

3

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/17509067

S Matsumoto

4

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/17509067

S Wakabayashi

5

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/17509067

R Matsutomo

6

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/17509067

K Takebayashi

7

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/17509067

T Inukai

8

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/17509067

publication date

17 May 2007

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/17509067

Diabetic Medicine

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/17509067

24

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/17509067

9

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/17509067

962-968

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/17509067

The mechanisms of action of PPARs

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02204.X

21 January 2018

Therapeutic roles of peroxisome proliferator-activated receptor agonists

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02204.X

21 January 2018

Thiazolidinediones in the treatment of insulin resistance and type II diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02204.X

21 January 2018

Thiazolidinediones

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02204.X

21 January 2018

Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02204.X

21 January 2018

Effects of troglitazone on blood concentrations of plasminogen activator inhibitor 1 in patients with type 2 diabetes and in lean and obese normal subjects

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02204.X

21 January 2018

The adipocyte-secreted protein Acrp30 enhances hepatic insulin action

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02204.X

21 January 2018

The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02204.X

21 January 2018

The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02204.X

21 January 2018

Effects of pioglitazone on metabolic parameters, body fat distribution, and serum adiponectin levels in Japanese male patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02204.X

21 January 2018

Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin. Implications fpr metabolic regulation and bioactivity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02204.X

21 January 2018

Role of disulfide bonds in Acrp30/adiponectin structure and signaling specificity. Different oligomers activate different signal transduction pathways

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02204.X

21 January 2018

Impaired multimerization of human adiponectin mutants associated with diabetes. Molecular structure and multimer formation of adiponectin.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02204.X

21 January 2018

Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02204.X

21 January 2018

Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02204.X

21 January 2018

A novel enzyme-linked immunosorbent assay specific for high-molecular-weight adiponectin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02204.X

21 January 2018

Comparison of serum high-molecular weight (HMW) adiponectin with total adiponectin concentrations in type 2 diabetic patients with coronary artery disease using a novel enzyme-linked immunosorbent assay to detect HMW adiponectin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02204.X

21 January 2018

Metabolic syndrome accompanied by hypercholesterolemia is strongly associated with proinflammatory state and impairment of fibrinolysis in patients with type 2 diabetes: synergistic effects of plasminogen activator inhibitor-1 and thrombin-activatab

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02204.X

21 January 2018

Antiatherogenic effect of pioglitazone in type 2 diabetic patients irrespective of the responsiveness to its antidiabetic effect

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02204.X

21 January 2018

Effects of pioglitazone on lipoproteins, inflammatory markers, and adipokines in nondiabetic patients with metabolic syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02204.X

21 January 2018

Pioglitazone increases circulating adiponectin levels and subsequently reduces TNF-alpha levels in Type 2 diabetic patients: a randomized study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02204.X

21 January 2018

Pioglitazone increases secretion of high-molecular-weight adiponectin from adipocytes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02204.X

21 January 2018

Effect of rosiglitazone on glucose and non-esterified fatty acid metabolism in Type II diabetic patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02204.X

21 January 2018

Comparison of metabolic effects of pioglitazone, metformin, and glimepiride over 1 year in Japanese patients with newly diagnosed Type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02204.X

21 January 2018

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02204.X

21 January 2018

Identifiers

10.1111/J.1464-5491.2007.02204.X

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/17509067

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/17509067

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47287831&oldid=2150390336"